Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials
Polypharmacy and potentially inappropriate medications (PIMs) are prevalent in older adults in hospital, and are associated with negative outcomes including adverse drug reactions, falls, confusion, hospitalisation and death. Deprescribing may reduce inappropriate polypharmacy and use of inappropriate medications.
The aim of this systematic review was to investigate the efficacy of deprescribing interventions in older inpatients to reduce PIMs and impact on clinical outcomes.
Ovid MEDLINE, Embase, Informit, International Pharmaceutical Abstracts, Scopus, PsycINFO, the Cochrane Central Register of Controlled Trials (CENTRAL) and CINAHL were searched for randomised controlled trials (RCTs) from 1996 to April 2017. RCTs reporting on deprescribing interventions to reduce PIMs in older hospitalised adults were eligible. Data were extracted, and study quality assessed. The primary outcome was reduction in PIMs. Where available, clinically relevant outcomes were assessed.
Nine RCTs (n = 2522 subjects) met the inclusion criteria. Deprescribing interventions were either pharmacist-led (n = 4), physician-led (n = 4) or multidisciplinary team-led (n = 1). Seven of the nine studies reported a statistically significant reduction in PIMs in the intervention group. There was no change in one study where there were zero PIMs on admission and discharge, and in the other study a reduction in PIMs that was not statistically significant was observed. There was significant heterogeneity in outcome measures and reporting. Few studies reported on the impact of deprescribing interventions on clinical outcomes. Reported clinical outcomes included drug-related problems (n = 3), quality of life (n = 2), mortality (n = 3), hospital readmissions (n = 4), falls (n = 3) and functional status (n = 2). Most studies reported a benefit in the intervention group that was not statistically significant. No notable harm was observed in the intervention group. There was a high risk of bias in the included studies.
The evidence available suggests that deprescribing interventions in hospital are feasible, generally effective at reducing PIMs and safe. However, the current evidence is limited, of low quality and the impact on clinical outcomes is unclear.
Compliance with Ethical Standards
No funding was used in the preparation of this manuscript. However, the findings will inform NSW Health Translational Research Grant 274, ‘Reducing Inappropriate Polypharmacy in Older Inpatients’, chief investigator Sarah Hilmer.
Conflict of interest
Janani Thillainadesan, Danijela Gnjidic, Sarah Green and Sarah Hilmer declare that they have no conflicts of interest relevant to the content of this review.
- 1.Australian Institute of Health and Welfare. Australia’s hospitals 2014–2015 at a glance. Health Services Series, No. 70. Catalogue No. HSE 175 Canberra, Australia; 2016.Google Scholar
- 8.Ni Chroinin D, Neto HM, Xiao D, Sandhu A, Brazel C, Farnham N, et al. Potentially inappropriate medications (PIMs) in older hospital in-patients: prevalence, contribution to hospital admission and documentation of rationale for continuation. Australas J Ageing. 2016;35(4):262–5.CrossRefPubMedGoogle Scholar
- 12.Wallace E, McDowell R, Bennett K, Fahey T, Smith SM. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271–7.CrossRefPubMedGoogle Scholar
- 19.Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter A, van Driel ML, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;28(3):CD007726. https://doi.org/10.1002/14651858.cd007726.pub2.Google Scholar
- 24.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Higgins JPT, Altman DG, Sterne JAC. Chapter 8: assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). ed: The Cochrane Collaboration, 2011.Google Scholar
- 30.Dalleur O, Boland B, Losseau C, Henrard S, Wouters D, Speybroeck N, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291–8. https://doi.org/10.1007/s40266-014-0157-5.CrossRefPubMedGoogle Scholar
- 32.Gillespie U, Alassaad A, Hammarlund-Udenaes M, Mörlin C, Henrohn D, Bertilsson M, et al. Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’(MAI, STOPP and STARTs’) ability to predict hospitalization–analyses from a randomized controlled trial. PLoS One. 2013;8(5):e62401.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55(5):658–65. https://doi.org/10.1111/j.1532-5415.2007.01132.x.CrossRefPubMedGoogle Scholar
- 36.Van der Linden L, Decoutere L, Walgraeve K, Milisen K, Flamaing J, Spriet I, et al. Combined use of the rationalization of home medication by an adjusted STOPP in older patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging. 2017;34(2):123–33. https://doi.org/10.1007/s40266-016-0424-8.CrossRefPubMedGoogle Scholar
- 39.Walsh KA, O’Riordan D, Kearney PM, Timmons S, Byrne S. Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists’ interventions in secondary care. Age Ageing. 2016;45(2):201–9. https://doi.org/10.1093/ageing/afv190.CrossRefPubMedGoogle Scholar
- 41.Meulendijk MC, Spruit MR, Drenth-van Maanen AC, Numans ME, Brinkkemper S, Jansen PAF, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP assistant’s usability. Drugs Aging. 2015;32(6):495–503. https://doi.org/10.1007/s40266-015-0270-0.CrossRefPubMedPubMedCentralGoogle Scholar